Arrowstreet Capital’s Aurora Cannabis ACB Stock Holding History

Arrowstreet Capital’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-137,185	Closed	-$17M	–	2298
2020 Q2	$17M	Buy	+137,185	New	+$15.6M	0.03%	568

Other funds holding ACB

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Arrowstreet Capital's ACB Position: Q3 2020 in Review

Arrowstreet Capital sold out of Aurora Cannabis (ACB) in Q3 2020, closing a stake of 137,185 shares — an estimated $17M sold.

Arrowstreet Capital first reported a position in ACB in Q2 2020 and held it in 1 quarter. The position peaked at $17M in Q2 2020. 234 funds tracked by Wall St. Rank hold ACB as of Q3 2020.

Arrowstreet Capital reported no remaining Aurora Cannabis position as of Q3 2020 after selling out during the quarter.
Arrowstreet Capital sold 137,185 Aurora Cannabis shares in Q3 2020, an estimated $17M.
Arrowstreet Capital first reported a position in Aurora Cannabis in Q2 2020 and held it in 1 quarter.
Arrowstreet Capital's Aurora Cannabis position peaked at $17M in Q2 2020.
234 funds tracked by Wall St. Rank held Aurora Cannabis as of Q3 2020.

Based on Arrowstreet Capital's 13F filing for Q3 2020, filed 12 Nov 2020.